Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 516

1.

Physiological and transcriptional response of Candida parapsilosis to exogenous tyrosol.

Jakab Á, Tóth Z, Nagy F, Nemes D, Bácskay I, Kardos G, Emri T, Pócsi I, Majoros L, Kovács R.

Appl Environ Microbiol. 2019 Aug 9. pii: AEM.01388-19. doi: 10.1128/AEM.01388-19. [Epub ahead of print]

PMID:
31399405
2.

Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.

Kovács R, Nagy F, Tóth Z, Bozó A, Balázs B, Majoros L.

Lett Appl Microbiol. 2019 Aug 6. doi: 10.1111/lam.13204. [Epub ahead of print]

PMID:
31385615
3.

Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis.

Prépost E, Tóth Z, Perlin DS, Gesztelyi R, Kardos G, Kovács R, Nagy F, Forgács L, Majoros L.

Infect Drug Resist. 2019 Jul 1;12:1805-1814. doi: 10.2147/IDR.S198764. eCollection 2019.

4.

Differential UVR8 signal across the stem controls UV-B-induced inflorescence phototropism.

Vanhaelewyn L, Viczián A, Prinsen E, Bernula P, Serrano AM, Arana MV, Ballare CL, Nagy F, Van Der Straeten D, Vandenbussche FJ.

Plant Cell. 2019 Jul 9. pii: tpc.00929.2018. doi: 10.1105/tpc.18.00929. [Epub ahead of print]

PMID:
31289115
5.

[18F-fluoro-deoxy-glucose positron emission tomography/computer tomography (18F-FDG-PET/CT) imaging in cardiology].

Besenyi Z, Nagy FT, Sághy L, Pávics L.

Orv Hetil. 2019 Jun;160(26):1015-1024. doi: 10.1556/650.2019.31414. Hungarian.

PMID:
31230470
6.

Farnesol increases the activity of echinocandins against Candida auris biofilms.

Nagy F, Tóth Z, Daróczi L, Székely A, Borman AM, Majoros L, Kovács R.

Med Mycol. 2019 May 25. pii: myz057. doi: 10.1093/mmy/myz057. [Epub ahead of print]

PMID:
31127836
7.

Diverse Exercises Similarly Reduce Older Adults' Mobility Limitations.

Tollár J, Nagy F, Moizs M, Tóth BE, Sanders LMJ, Hortobágyi T.

Med Sci Sports Exerc. 2019 Sep;51(9):1809-1816. doi: 10.1249/MSS.0000000000002001.

PMID:
30973482
8.

[Periodontal disease, a risk factor for atherosclerotic cardiovascular disease].

Gheorghita D, Eördegh G, Nagy F, Antal M.

Orv Hetil. 2019 Mar;160(11):419-425. doi: 10.1556/650.2019.31301. Hungarian.

PMID:
30852909
9.

Activity painting: PET images of freely defined activity distributions applying a novel phantom technique.

Forgacs A, Kallos-Balogh P, Nagy F, Krizsan AK, Garai I, Tron L, Dahlbom M, Balkay L.

PLoS One. 2019 Jan 25;14(1):e0207658. doi: 10.1371/journal.pone.0207658. eCollection 2019.

10.

Detection of myocardial inflammation by 18F-FDG-PET/CT in patients with systemic sclerosis without cardiac symptoms: a pilot study.

Besenyi Z, Ágoston G, Hemelein R, Annamária B, Nagy FT, Varga A, Kovács L, Pávics L.

Clin Exp Rheumatol. 2018 Dec 7. [Epub ahead of print]

PMID:
30557130
11.

[Transfer of care of adolescent inflammatory bowel disease patients without longitudinal transition. Lesson from 10 years experiences].

Szántó K, Szűcs D, Vass N, Várkonyi Á, Bálint A, Bor R, Fábián A, Milassin Á, Rutka M, Szepes Z, Nagy F, Molnár T, Farkas K.

Orv Hetil. 2018 Nov;159(44):1789-1793. doi: 10.1556/650.2018.31198. Hungarian.

PMID:
30392410
12.

Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.

Tóth Z, Kardos T, Kovács R, Kardos G, Nagy F, Prépost E, Barta Z, Takacs I, Majoros L.

Mycopathologia. 2018 Dec;183(6):905-912. doi: 10.1007/s11046-018-0302-5. Epub 2018 Oct 31.

PMID:
30382508
13.

Vastly Different Exercise Programs Similarly Improve Parkinsonian Symptoms: A Randomized Clinical Trial.

Tollár J, Nagy F, Hortobágyi T.

Gerontology. 2019;65(2):120-127. doi: 10.1159/000493127. Epub 2018 Oct 26.

PMID:
30368495
14.

Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.

Nagy F, Tóth Z, Bozó A, Czeglédi A, Rebenku I, Majoros L, Kovács R.

Med Mycol. 2018 Oct 18. doi: 10.1093/mmy/myy108. [Epub ahead of print]

PMID:
30339227
15.

Two-Year Agility Maintenance Training Slows the Progression of Parkinsonian Symptoms.

Tollár J, Nagy F, Kovács N, Hortobágyi T.

Med Sci Sports Exerc. 2019 Feb;51(2):237-245. doi: 10.1249/MSS.0000000000001793.

PMID:
30303934
16.

Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort.

Bálint A, Rutka M, Kolar M, Bortlik M, Duricova D, Hruba V, Lukas M, Mitrova K, Malickova K, Lukas M, Szepes Z, Nagy F, Palatka K, Lovas S, Végh Z, Kürti Z, Csontos Á, Miheller P, Nyári T, Bor R, Milassin Á, Fábián A, Szántó K, Lakatos PL, Molnár T, Farkas K.

Expert Opin Biol Ther. 2018 Nov;18(11):1181-1187. doi: 10.1080/14712598.2018.1530758. Epub 2018 Oct 9.

PMID:
30277084
17.

Smart Nanoparticles for Selective Immobilization of Acid Phosphatases.

Nagy F, Tasnádi G, Balogh-Weiser D, Bell E, Hall M, Faber K, Poppe L.

ChemCatChem. 2018 Aug 21;10(16):3490-3499. doi: 10.1002/cctc.201800405. Epub 2018 Jul 17.

18.

ELONGATED HYPOCOTYL 5 mediates blue light signalling to the Arabidopsis circadian clock.

Hajdu A, Dobos O, Domijan M, Bálint B, Nagy I, Nagy F, Kozma-Bognár L.

Plant J. 2018 Dec;96(6):1242-1254. doi: 10.1111/tpj.14106. Epub 2018 Oct 27.

PMID:
30256479
19.

Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center.

Szántó K, Nyári T, Bálint A, Bor R, Milassin Á, Rutka M, Fábián A, Szepes Z, Nagy F, Molnár T, Farkas K.

PLoS One. 2018 Jul 30;13(7):e0200824. doi: 10.1371/journal.pone.0200824. eCollection 2018.

20.

Interaction between Different Pharmaceutical Excipients in Liquid Dosage Forms-Assessment of Cytotoxicity and Antimicrobial Activity.

Nemes D, Kovács R, Nagy F, Mező M, Poczok N, Ujhelyi Z, Pető Á, Fehér P, Fenyvesi F, Váradi J, Vecsernyés M, Bácskay I.

Molecules. 2018 Jul 23;23(7). pii: E1827. doi: 10.3390/molecules23071827.

21.

Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.

Kardos T, Kovács R, Kardos G, Varga I, Bozó A, Tóth Z, Nagy F, Majoros L.

J Chemother. 2018 Jul;30(4):233-239. doi: 10.1080/1120009X.2018.1487150. Epub 2018 Jul 20.

PMID:
30025501
22.

A High-Intensity Multicomponent Agility Intervention Improves Parkinson Patients' Clinical and Motor Symptoms.

Tollár J, Nagy F, Kovács N, Hortobágyi T.

Arch Phys Med Rehabil. 2018 Dec;99(12):2478-2484.e1. doi: 10.1016/j.apmr.2018.05.007. Epub 2018 Jun 7.

PMID:
29886075
23.

[Childhood sporadic type of hemiplegic migraine with arteria cerebri media hypoperfusion].

Nagy C, Bajzik G, Skobrák A, Csorba E, Lajtai A, Balogh G, Nagy F, Vajda Z.

Ideggyogy Sz. 2017 Sep 30;70(9-10):343-348. doi: 10.18071/isz.70.0343. Hungarian.

PMID:
29870626
24.

The Use of Complementary and Alternative Medicine Is Less Frequent in Patients with Inflammatory Bowel Disease Than in Patients with Other Chronic Gastrointestinal Disorders.

Fábián A, Rutka M, Ferenci T, Bor R, Bálint A, Farkas K, Milassin Á, Szántó K, Lénárt Z, Nagy F, Szepes Z, Molnár T.

Gastroenterol Res Pract. 2018 Apr 3;2018:9137805. doi: 10.1155/2018/9137805. eCollection 2018.

25.

Comparison of Platelet Function Guided Versus Unguided Treatment With P2Y12 Inhibitors in Patients With Acute Myocardial Infarction (from the Hungarian Myocardial Infarction Registry).

Komócsi A, Aradi D, Szűk T, Nagy GG, Noori E, Ruzsa Z, Kiss RG, Andrássy P, Nagy L, Nagy FT, Lupkovics G, Kőszegi Z, Dézsi CA, Papp E, Molnár Z, Kupó P, Ofner P, Merkely B, Jánosi A.

Am J Cardiol. 2018 May 15;121(10):1129-1137. doi: 10.1016/j.amjcard.2018.01.032. Epub 2018 Feb 13.

26.

Autolytic hydrolases affect sexual and asexual development of Aspergillus nidulans.

Emri T, Vékony V, Gila B, Nagy F, Forgács K, Pócsi I.

Folia Microbiol (Praha). 2018 Sep;63(5):619-626. doi: 10.1007/s12223-018-0601-8. Epub 2018 Mar 30.

PMID:
29603054
27.

[Autoimmune encephalitis: possibilities in the laboratory investigation].

Böröcz K, Hayden Z, Mészáros V, Csizmadia Z, Farkas K, Kellermayer Z, Balogh P, Nagy F, Berki T.

Orv Hetil. 2018 Jan;159(3):107-112. doi: 10.1556/650.2018.30951. Hungarian.

PMID:
29332416
28.

How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system.

Bálint A, Farkas K, Szepes Z, Nagy F, Szűcs M, Tiszlavicz L, Bor R, Milassin Á, Rutka M, Fábián A, Molnár T.

BMC Gastroenterol. 2018 Jan 8;18(1):7. doi: 10.1186/s12876-017-0725-3.

29.

Extending knowledge of the clinical picture of Balkan adder (Vipera berus bosniensis) envenoming: The first photographically-documented neurotoxic case from South-Western Hungary.

Varga C, Malina T, Alföldi V, Bilics G, Nagy F, Oláh T.

Toxicon. 2018 Mar 1;143:29-35. doi: 10.1016/j.toxicon.2017.12.053. Epub 2018 Jan 2.

PMID:
29305081
30.

[Efficacy of the population-based pilot colorectal screening program. Hungary, Csongrád county, 2015].

Rutka M, Molnár T, Bor R, Farkas K, Fábián A, Győrfi M, Bálint A, Milassin Á, Szűcs M, Tiszlavicz L, Nagy F, Szepes Z.

Orv Hetil. 2017 Oct;158(42):1658-1667. doi: 10.1556/650.2017.30822. Hungarian.

PMID:
29037058
31.

[Neuroacanthocytosis diagnosis with new generation whole exome sequencing].

Hadzsiev K, Szőts M, Fekete A, Balikó L, Boycott K, Nagy F, Melegh B.

Orv Hetil. 2017 Oct;158(42):1681-1684. doi: 10.1556/650.2017.30880. Hungarian.

PMID:
29037056
32.

In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.

Nagy F, Bozó A, Tóth Z, Daróczi L, Majoros L, Kovács R.

Med Mycol. 2018 Jun 1;56(4):493-500. doi: 10.1093/mmy/myx062.

PMID:
28992253
33.

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort.

Gonczi L, Gecse KB, Vegh Z, Kurti Z, Rutka M, Farkas K, Golovics PA, Lovasz BD, Banai J, Bene L, Gasztonyi B, Kristof T, Lakatos L, Miheller P, Nagy F, Palatka K, Papp M, Patai A, Salamon A, Szamosi T, Szepes Z, Toth GT, Vincze A, Szalay B, Molnar T, Lakatos PL.

Inflamm Bowel Dis. 2017 Nov;23(11):1908-1915. doi: 10.1097/MIB.0000000000001237.

PMID:
28922253
34.

Analysis of risk factors - especially different types of plexitis - for postoperative relapse in Crohn's disease.

Milassin Á, Sejben A, Tiszlavicz L, Reisz Z, Lázár G, Szűcs M, Bor R, Bálint A, Rutka M, Szepes Z, Nagy F, Farkas K, Molnár T.

World J Gastrointest Surg. 2017 Jul 27;9(7):167-173. doi: 10.4240/wjgs.v9.i7.167.

35.

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center.

Farkas K, Rutka M, Ferenci T, Nagy F, Bálint A, Bor R, Milassin Á, Fábián A, Szántó K, Végh Z, Kürti Z, Lakatos PL, Szepes Z, Molnár T.

Expert Opin Biol Ther. 2017 Nov;17(11):1325-1332. doi: 10.1080/14712598.2017.1363885. Epub 2017 Aug 18.

PMID:
28819991
36.

Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort.

Bálint A, Rutka M, Végh Z, Kürti Z, Gecse KB, Banai J, Bene L, Gasztonyi B, Kristóf T, Lakatos L, Miheller P, Palatka K, Patai Á, Salamon Á, Szamosi T, Szepes Z, Tóth GT, Vincze Á, Bor R, Milassin Á, Fábián A, Nagy F, Kolar M, Bortlik M, Duricova D, Hruba V, Lukas M, Mitrova K, Malickova K, Lukas M, Lakatos PL, Molnár T, Farkas K.

Expert Opin Drug Saf. 2017 Aug;16(8):885-890. doi: 10.1080/14740338.2017.1323330. Epub 2017 May 26.

PMID:
28504555
37.

Global brain atrophy and metabolic dysfunction in LGI1 encephalitis: A prospective multimodal MRI study.

Szots M, Blaabjerg M, Orsi G, Iversen P, Kondziella D, Madsen CG, Garde E, Magnusson PO, Barsi P, Nagy F, Siebner HR, Illes Z.

J Neurol Sci. 2017 May 15;376:159-165. doi: 10.1016/j.jns.2017.03.020. Epub 2017 Mar 16.

PMID:
28431605
38.

Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease.

Bor R, Farkas K, Fábián A, Bálint A, Milassin Á, Rutka M, Matuz M, Nagy F, Szepes Z, Molnár T.

PLoS One. 2017 Mar 31;12(3):e0172916. doi: 10.1371/journal.pone.0172916. eCollection 2017.

39.

Activity of exogenous tyrosol in combination with caspofungin and micafungin against Candida parapsilosis sessile cells.

Kovács R, Tóth Z, Nagy F, Daróczi L, Bozó A, Majoros L.

J Appl Microbiol. 2017 Jun;122(6):1529-1536. doi: 10.1111/jam.13452. Epub 2017 May 3.

PMID:
28321957
40.

Calcium signalling through L-type calcium channels: role in pathophysiology of spinal nociceptive transmission.

Roca-Lapirot O, Radwani H, Aby F, Nagy F, Landry M, Fossat P.

Br J Pharmacol. 2018 Jun;175(12):2362-2374. doi: 10.1111/bph.13747. Epub 2017 Mar 24. Review.

41.

Expression of the eRF1 translation termination factor is controlled by an autoregulatory circuit involving readthrough and nonsense-mediated decay in plants.

Nyikó T, Auber A, Szabadkai L, Benkovics A, Auth M, Mérai Z, Kerényi Z, Dinnyés A, Nagy F, Silhavy D.

Nucleic Acids Res. 2017 Apr 20;45(7):4174-4188. doi: 10.1093/nar/gkw1303.

42.

Expression of the UVR8 photoreceptor in different tissues reveals tissue-autonomous features of UV-B signalling.

Bernula P, Crocco CD, Arongaus AB, Ulm R, Nagy F, Viczián A.

Plant Cell Environ. 2017 Jul;40(7):1104-1114. doi: 10.1111/pce.12904. Epub 2017 Mar 27.

PMID:
28058744
43.

New insights of red light-induced development.

Viczián A, Klose C, Ádám É, Nagy F.

Plant Cell Environ. 2017 Nov;40(11):2457-2468. doi: 10.1111/pce.12880. Epub 2017 Feb 18. Review.

PMID:
27943362
44.

Prospective Comparison of Magnetic Resonance Imaging, Transrectal and Transperineal Sonography, and Surgical Findings in Complicated Perianal Crohn Disease.

Bor R, Farkas K, Bálint A, Szűcs M, Ábrahám S, Milassin Á, Rutka M, Nagy F, Milassin P, Szepes Z, Molnár T.

J Ultrasound Med. 2016 Nov;35(11):2367-2372. Epub 2016 Sep 14.

PMID:
27629757
45.

Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis.

Farkas K, Rutka M, Golovics PA, Végh Z, Lovász BD, Nyári T, Gecse KB, Kolar M, Bortlik M, Duricova D, Machkova N, Hruba V, Lukas M, Mitrova K, Malickova K, Bálint A, Nagy F, Bor R, Milassin Á, Szepes Z, Palatka K, Lakatos PL, Lukas M, Molnár T.

J Crohns Colitis. 2016 Nov;10(11):1273-1278. Epub 2016 Apr 21.

PMID:
27106537
46.

Four cases of GABAB receptor encephalitis.

Szőts M, Blaabjerg M, Kondziella D, Herceg M, Diószeghy P, Bajzik G, Berki T, Kálmán E, Nagy F, Illés Z.

Ideggyogy Sz. 2016 Jul 30;69(7-8):281-287. doi: 10.18071/isz.69.0281.

PMID:
29465894
47.

[Neoadjuvant treatment as a limiting factor to rectal ultrasonography].

Fábián A, Bor R, Bálint A, Farkas K, Milassin Á, Rutka M, Tiszlavicz L, Nagy F, Molnár T, Szepes Z.

Orv Hetil. 2016 Jul;157(30):1193-7. doi: 10.1556/650.2016.30432. Hungarian.

PMID:
27452069
48.

Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum.

Rutka M, Bor R, Bálint A, Fábián A, Milassin Á, Nagy F, Szepes Z, Szűcs M, Tiszlavicz L, Farkas K, Molnár T.

Mediators Inflamm. 2016;2016:2492081. doi: 10.1155/2016/2492081. Epub 2016 Jun 16.

49.

Gastroduodenal Involvement in Asymptomatic Crohn's Disease Patients in Two Areas of Emerging Disease: Asia and Eastern Europe.

Farkas K, Chan H, Rutka M, Szepes Z, Nagy F, Tiszlavicz L, Nyári T, Tang W, Wong G, Tang R, Lo A, Cheung C, Wong S, Lui R, Molnár T, Ng SC.

J Crohns Colitis. 2016 Dec;10(12):1401-1406. Epub 2016 Jun 9.

PMID:
27282400
50.

[Long-term adalimumab therapy in ulcerative colitis in clinical practice: result of the Hungarian multicenter prospective study].

Rutka M, Bálint A, Farkas K, Palatka K, Lakner L, Miheller P, Rácz I, Hegede G, Vincze Á, Horváth G, Szabó A, Nagy F, Szepes Z, Gábor Z, Zsigmond F, Zsóri Á, Juhász M, Csontos Á, Szűcs M, Bor R, Milassin Á, Molnár T.

Orv Hetil. 2016 May 1;157(18):706-11. doi: 10.1556/650.2016.30429. Hungarian.

PMID:
27106726

Supplemental Content

Support Center